Revitope
BioTech/Drugs - Cambridge, MA, US
Revitope Details
Revitope is an early stage biotechnology company focused on developing the next-generation of T cell redirecting biologics. Immune-based therapies are redefining how cancer is treated as clinical studies demonstrate unprecedented deep and durable responses in multiple cancers. In particular redirecting T cells to tumors is a successful strategy for immunotherapy of liquid tumors. However, unleashing a potent immune response that is entirely focused on the tumor continues to be elusive.Revitope is developing a new class of biologic prodrugs we call Programmable Antibody Circuits or PACs that are engineered to focus immune activation to the cancer cell surface while expanding the antigenic targeting space.
Revitope Technologies
Email Providers
Mimecast
Domain Name Services
Dyn Managed DNS
CMS
WP Engine
Other
Mobile Friendly
Hosting
Google Cloud Hosting